Genitourinary Cancer
Conference Coverage
Adding Short-term ADT to High-Dose Radiotherapy Benefits Some Prostate Cancers
Patients with intermediate- or high-risk localized prostate cancer who had PSA levels under 30 ng/mL and no clinical involvement of the seminal...
Conference Coverage
IMRT vs Proton Therapy for Early Prostate Cancer?
The results of a new trial demonstrate ‘equivalent outcomes, with superb cancer control rates and extremely low toxicity from both treatments.’
Feature
Popular Weight Loss Drugs Now for Patients With Cancer?
Research suggests that obesity can reduce the effectiveness of cancer therapies.
From the Journals
Does Medicare Advantage Offer Higher-Value Chemotherapy?
Researchers conducted a cohort study to look at Medicare Advantage enrollment and treatment patterns for patients with cancer receiving...
Feature
AACR Cancer Progress Report: Big Strides and Big Gaps
The report focused on strides made in cancer care, prevention, and early detection and highlighted areas where more research and attention are...
From the Journals
Cancer Risk: Are Pesticides the New Smoking?
A recent study evaluated cancer risks in the US population using a model that accounts for pesticide use and adjusts for various factors.
Latest News
Beyond Weight Loss, Limited Bariatric Surgery Benefits in Older Adults
“The findings from this study suggest a limited role of bariatric surgery in older patients for the prevention of obesity-related cancer or...
Feature
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?
Researchers analyzed whole genome sequencing data from 10,866 women in the WHI to explore possible associations between CHIP, mCA, and solid...
From the Journals
Adjuvant Everolimus Offers No Survival Benefit in Non–Clear Cell RCC
Researchers evaluated everolimus in the adjuvant setting in patients with either clear cell or non–clear cell RCC at a high risk for recurrence...
From the Journals
Cancer Cases, Deaths in Men Predicted to Surge by 2050
Researchers analyzed data from the 2022 Global Cancer Observatory (GLOBOCAN), which provides national-level estimates for cancer cases and deaths...
Feature
Could Baseline MRIs Reshape Prostate Cancer Risk Assessment?
Investigators analyzed data from men with prostate cancer who had MRI within 6 months before or after their initial biopsy.